MIT Scientists Create Injectable 'Satellite Livers' for Transplant Patients

New hydrogel microsphere technology could help thousands avoid liver transplant surgery.

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

MIT scientists have developed an innovative solution to help the over 10,000 Americans awaiting liver transplants. Their 'injectable, self-assembling' technology uses hydrogel microspheres packed with liver cells that can be injected into a patient's body, where they then solidify into functional 'satellite livers' that integrate with the patient's existing blood vessels.

Why it matters

America's liver transplant waitlist is notoriously long, with many patients dying before receiving a donor organ. MIT's new injectable liver graft technology offers a potential solution that could dramatically increase access to liver transplants without the need for complex and risky surgery.

The details

The INSITE technology (Injected, Self-assembled, Image-guided Tissue Ensembles) mixes liver cells called hepatocytes with tiny hydrogel spheres and supportive fibroblasts. When injected into the body, these 'tissue cocktails' assemble themselves into functional liver grafts that can survive for at least 8 weeks in mouse studies. The microspheres provide a supportive 'niche' for the liver cells, allowing them to thrive and integrate with the host's blood vessels much faster than direct cell injections.

  • MIT scientists have been researching this 'microliver' technology for over a decade.
  • The latest mouse studies showed the injectable liver grafts remained viable and functional for at least 8 weeks.

The players

Sangeeta Bhatia

A professor at MIT and the lead researcher on the injectable liver graft technology.

Vardhman Kumar

A researcher on Bhatia's team who explains how the hydrogel microspheres provide a supportive 'niche' for the liver cells.

LyGenesis

A competing company that is growing mini-livers inside lymph nodes, though their approach requires more invasive procedures.

Got photos? Submit your photos here. ›

What they’re saying

“These microspheres provide the hepatocytes with a niche where they can stay localized and become connected to the host circulation much faster.”

— Vardhman Kumar, Researcher (gadgetreview.com)

What’s next

MIT's approach still faces limitations, including the need for immunosuppressive drugs, but the researchers believe future iterations could use 'stealth' cells or local drug delivery to avoid that complication. Human trials for the injectable liver grafts remain years away, but the team's decade of microliver research suggests this technology has real potential to help solve the organ shortage crisis.

The takeaway

MIT's injectable, self-assembling liver graft technology represents a significant step forward in regenerative medicine, offering a potential solution to help the thousands of Americans awaiting life-saving liver transplants without the need for complex and risky surgery.